Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial

INTRODUCTION: Erythropoietin (EPO) is a commonly used option in the treatment of chemotherapy-induced anaemia (CIA). However, ∼30–50% of patients fail to achieve an adequate response after initial treatment. Prior studies have demonstrated that intravenous iron might synergistically improve therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lin, Jiang, Hong, Gao, Wei, Tu, Ye, Zhou, Ying, Li, Xi, Zhu, Zhe, Jiang, Qixin, Zhan, Haifeng, Yu, Jiangming, Fu, Chuangang, Gao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073518/
https://www.ncbi.nlm.nih.gov/pubmed/27855097
http://dx.doi.org/10.1136/bmjopen-2016-012231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073518/
https://www.ncbi.nlm.nih.gov/pubmed/27855097
http://dx.doi.org/10.1136/bmjopen-2016-012231

Ejemplares similares